Navigation Links
Neuro-Biotech's Solution for a Doctor near You: Early Detection for Alzheimer's and Chronic Fatigue Syndrome!
Date:9/20/2010

BASEL, Switzerland, Sept. 20 /PRNewswire-FirstCall/ - Neuro-Biotech Corporation (PINKSHEETS: MRES) (OTCQB: MRES) is a worldwide based biotechnological enterprise involved in the unique international niche of clinical neuroscience diagnostic testing. Neuro-Biotech's presently has the opportunity to market 12 clinical "Neuro Blood Tests" through partnerships. Neuro-Biotech's proprietary diagnostic tests are without equal in being rapidly done as an essential complement to current clinical laboratory testing procedures, by being non-invasive, sensitive, and reliable. This will provide general practitioners and specialists alike, useful medical parameters in the analysis and treatment of workplace stress-related diseases and mental-health disorders, such as Alzheimer's.

As a result of more than 20 years of research and development (R&D), Neuro-Biotech Corp.'s specific expertise is the understanding of the communication between the brain and the human body and their various influences on the peripheral systems, in order to maintain the internal equilibrium of a person's state of mind.

This exclusive understanding of the relationships between the neurotransmitter families within the brain led to the development of a portfolio of in vitro diagnostic blood tests. They will be used for the detection, prevention, monitoring and follow-up of the major psycho-social environmental diseases. They can be stress-related, socio-professional and occupational diseases, such as Chronic Fatigue Syndrome (CFS), Great Anxiety (GA), Panic Syndrome (PS); Cardiovascular diseases like Essential Hypertension or Arrhythmia; Neurodegenerative diseases such as Alzheimer or Parkinson's Disease as well as Mental-Health Disorders in the vein of Depression and Schizophrenia

Caregivers can now evaluate and establish an individual's ability to react to stress by monitoring bio-indicators within the blood or other biological fluids. Efficient and improved patient supervision, treatment and follow-up care can be instituted.

Clinical Neuroscience-related diseases can be difficult to diagnose and complex to treat. If we don't know the full state of health of an individual and the progression of the therapy... How can we truly manage the care and rehabilitation? Neuro-Biotech Corp. has the solution!


'/>"/>
SOURCE Neuro-Biotech Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses
2. Marrone Bio Innovations to Present Invasive Mussel Control Solution
3. Applied Precision Installs New DeltaVision
4. OMX® Super-Resolution Imaging System in the Light Microscopy Imaging Center at Indiana University
5. Scientists achieve highest-resolution MRI of a magnet
6. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
7. Pfizer Wins CIO 100 Award for Patient Enrollment Optimization Solution From DecisionView
8. BioSpec Global Solutions Inc. Enters into talks with possible Chinese partner
9. Case Western Reserve University-led team takes high resolution photo of a K+ channel
10. Promega Now Offers Complete Solution for Profiling Kinase Inhibitor Compounds Against the Human Kinome
11. Haydon Kerk Motion Solutions Introduces the RGS04 Dual Carriage Linear Rail and Programmable Actuator Assembly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):